Jagsonpal Pharmaceuticals Ltd Q4 FY2026 PAT falls QoQ to Rs. 8.76 crores

has reported Standalone financial results for the period ended March 31, 2026.

Financial Results (Q4 FY2026) - QoQ Comparison

The company has reported total income of Rs. 67.371 crores during the period ended March 31, 2026 as compared to Rs. 75.920 crores during the period ended December 31, 2025.

The company has posted net profit / (loss) of Rs. 8.762 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 10.951 crores for the period ended December 31, 2025.

The company has reported EPS of Rs. 1.21 for the period ended March 31, 2026 as compared to Rs. 1.65 for the period ended December 31, 2025.

Financials	Q4 FY2026	Q3 FY2026	% Change
Total Income	₹ 67.371 crs	₹75.920 crs	-11.26%
Net Profit	₹8.762 crs	₹10.951 crs	-19.99%
EPS	₹1.21	₹1.65	-26.67%

Financial Results (Q4 FY2026) - YoY Comparison

The company has reported total income of Rs. 67.371 crores during the period ended March 31, 2026 as compared to Rs.61.330 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs.8.762 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.6.583 crores for the period ended March 31, 2025.

The company has reported EPS of Rs.1.21 for the period ended March 31, 2026 as compared to Rs.0.98 for the period ended March 31, 2025.

Financials	Q4 FY2026	Q4 FY2025	% Change
Total Income	₹ 67.371 crs	₹61.330 crs	9.85%
Net Profit	₹8.762 crs	₹6.583 crs	33.10%
EPS	₹1.21	₹0.98	23.47%

Financial Results (Year Ended FY2026) - YoY Comparison

The company has reported total income of Rs.299.220 crores during the Financial Year ended March 31, 2026 as compared to Rs.276.906 crores during the Financial Year ended March 31, 2025.

The company has posted net profit / (loss) of Rs.43.082 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.55.361 crores for the Financial Year ended March 31, 2025.

The company has reported EPS of Rs.6.31 for the Financial Year ended March 31, 2026 as compared to Rs.8.22 for the Financial Year ended March 31, 2025.

Financials	Year Ended FY2026	Year Ended FY2025	% Change
Total Income	₹299.220 crs	₹276.906 crs	8.06%
Net Profit	₹43.082 crs	₹55.361 crs	-22.18%
EPS	₹6.31	₹8.22	-23.24%

Source : Equity Bulls

Keywords

JagsonpalPharmaceuticals Q4FY26 Q4FY2026 FY26 FY2026 ResultUpdate